
Chugai Pharmaceutical Ltd (PK) (CHGCY)
USOTC
The current CHGCY market cap is 82.28B. The company's latest EPS is JPY 117.7744 and P/E is 0.40.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Revenue | 787.01B | 999.76B | 1.26T | 1.14T | 1.17T |
Operating Income | 301.23B | 419.36B | 531.18B | 439.17B | 542B |
Net Income | 214.73B | 303B | 374.43B | 325.47B | 387.32B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 1.24T | 1.54T | 1.87T | 1.93T | 2.21T |
Total Liabilities | 255.5B | 350.68B | 445.37B | 306.97B | 306.87B |
Total Equity | 980B | 1.19T | 1.42T | 1.63T | 1.9T |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Operating | 205.04B | 279.63B | 244.11B | 409.93B | 447.6B |
Investing | -98.31B | -118.93B | -145.99B | -37.29B | -227.37B |
Financing | -99.5B | -107.41B | -145.64B | -139.33B | -141.01B |
Market Cap | 82.28B |
Price to Earnings Ratio | 0.40 |
Price to Sales Ratio | 0.13 |
Price to Cash Ratio | 0.29 |
Price to Book Ratio | 0.08 |
Dividend Yield | 1.08% |
Shares Outstanding | 3.29B |
Average Volume (1 week) | 104.19k |
Average Volume (1 Month) | 178.98k |
52 Week Change | 16.10% |
52 Week High | 27.19 |
52 Week Low | 14.52 |
Spread (Intraday) | 1.98 (7.54%) |
Company Name | Chugai Pharmaceutical Ltd (PK) |
Address |
2-1-1 muromachi-nihonbashi chuo, tokyo 103-8324 |
Website | https://www.chugai-pharm.co.jp |
Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.